MTCH2 silencing disrupted mitochondrial functions, induced oxidative damage, hindered cell migration/invasion, inhibited pro-survival AKT signaling, and increased temozolomide sensitivity in glioma cells [19]. The gene discussed is MTCH2; the disease is glioma.